These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1407412)

  • 41. Opioid peptides in the cerebrospinal fluid of Alzheimer patients.
    Muhlbauer M; Metcalf JC; Robertson JT; Fridland G; Desiderio DM
    Biomed Chromatogr; 1986 Aug; 1(4):155-8. PubMed ID: 3506828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
    Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
    Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.
    Selley ML; Close DR; Stern SE
    Neurobiol Aging; 2002; 23(3):383-8. PubMed ID: 11959400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
    J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
    Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Endothelin in the plasma and cerebrospinal fluid of patients after head injury].
    Beuth W; Kasprzak H; Kotschy M; Woźniak B; Kulwas A; Sniegocki M
    Neurol Neurochir Pol; 2001; 35 Suppl 5():125-9. PubMed ID: 11935673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
    Davis BM; Mohs RC; Greenwald BS; Mathé AA; Johns CA; Horvath TB; Davis KL
    J Am Geriatr Soc; 1985 Nov; 33(11):741-8. PubMed ID: 2414354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.
    Davis KL; Hsieh JY; Levy MI; Horvath TB; Davis BM; Mohs RC
    Psychopharmacol Bull; 1982 Oct; 18(4):193-5. PubMed ID: 7156289
    [No Abstract]   [Full Text] [Related]  

  • 51. Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study.
    Alafuzoff I; Adolfsson R; Grundke-Iqbal I; Winblad B
    Acta Neuropathol; 1987; 73(2):160-6. PubMed ID: 3300132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.
    Lang V; Zille M; Infante-Duarte C; Jarius S; Jahn H; Paul F; Ruprecht K; Pina AL
    J Neurol Sci; 2017 Apr; 375():123-128. PubMed ID: 28320113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    Costa M; Horrillo R; Ortiz AM; Pérez A; Mestre A; Ruiz A; Boada M; Grancha S
    J Alzheimers Dis; 2018; 63(4):1395-1404. PubMed ID: 29782326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.
    Leonardi A; Gandolfo C; Caponnetto C; Arata L; Vecchia R
    J Neurol Sci; 1985 Feb; 67(2):253-61. PubMed ID: 3981221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA; Pirttilä T
    Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.
    Brosseron F; Traschütz A; Widmann CN; Kummer MP; Tacik P; Santarelli F; Jessen F; Heneka MT
    Alzheimers Res Ther; 2018 Feb; 10(1):25. PubMed ID: 29482610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type.
    Gold M; Chen MF; Johnson K
    Arch Neurol; 1995 Nov; 52(11):1081-6. PubMed ID: 7487560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.